6 Viral Virulence and Defences
In this section:
Content in this section includes:
Although viral pathogens are not similar to bacterial pathogens in terms of structure, some of the properties that contribute to their virulence are similar. Viruses use adhesins to facilitate adhesion to host cells and certain enveloped viruses rely on antigenic variation to avoid the host immune defences. These virulence factors are discussed in more detail in the following sections.
Viral Adhesins
One of the first steps in any viral infection is adhesion of the virus to specific receptors on the surface of cells. This process is mediated by adhesins that are part of the viral capsid or membrane envelope. The interaction of viral adhesins with specific cell receptors defines the preferential targeting (tropism) of viruses for specific cells, tissues and organs in the body. The spike protein haemagglutinin found on Influenza virus is an example of a viral adhesin; it allows the virus to bind to the sialic acid on the membrane of host respiratory and intestinal cells. Another viral adhesin is the glycoprotein gp20, found on HIV. For HIV to infect cells of the immune system, it must interact with two receptors on the surface of cells. The first interaction involves binding between gp120 and the CD4 cellular marker that is found on some essential immune system cells. However, before viral entry into the cell can occur, a second interaction between gp120 and one of two chemokine receptors (CCR5 and CXCR4) must occur. The adhesins for some common viral pathogens and the specific sites to which these adhesins allow viruses to attach are listed in Table 3.3. In some disease states, these adhesion site proteins can be upregulated (eg in COVID-19) (Brake et al., 2021).
Table 3.3 Viral adhesins and their host attachment sites
| Pathogen | Disease | Adhesin | Attachment site |
|---|---|---|---|
| Influenza virus | Influenza | Haemagglutinin | Sialic acid of respiratory and intestinal cells |
| Herpes simplex virus I or II | Oral herpes, gential herpes | Glycloproteins gB, gC, gD | Heparan sulphate on mucosal surfaces of the mouth and gentials |
| Human immunodeficency virus | HIV/AIDS | Glycoprotein gp120 | CD4 and CCR5 or CXCR4 of immune system cells |
Antigenic Variation in Viruses
Antigenic variation also occurs in certain types of enveloped viruses, including influenza viruses, which exhibit two forms of antigenic variation: antigenic drift and antigenic shift (Figure 3.14). Antigenic drift is the result of point mutations causing slight changes in the spike proteins haemagglutinin (H) and neuraminidase (N), whereas, antigenic shift is a major change in spike proteins due to gene reassortment. This reassortment for antigenic shift typically occurs when two different influenza viruses infect the same host.
The rate of antigenic variation in influenza viruses is very high, making it difficult for the immune system to recognise the many different strains of Influenza virus. Although the body may develop immunity to one strain through natural exposure or vaccination, antigenic variation results in the continual emergence of new strains that the immune system will not recognise. This is the main reason that vaccines against Influenza virus must be given annually. Each year’s influenza vaccine provides protection against the most prevalent strains for that year, but new or different strains may be more prevalent the following year.
